Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration.

NCT07847151 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07847151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration.
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
January 2, 2027
Completion date
January 2, 2030
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related (dry) macular degeneration, age-related macular degeneration (amd), amd and macular edema, amd population - intermediate or advanced amd, neovascular (wet) age-related macular degeneration